Pathophysiological roles of interleukin-8/CXCL8 in pulmonary diseases

Naofumi Mukaida1
1Division of Molecular Bioregulation, Cancer Research Institute, Kanazawa University, 13-1 Takara-machi, Kanazawa, 920-0934, Japan

Tóm tắt

Fifteen years have passed since the first description of interleukin (IL)-8/CXCL8 as a potent neutrophil chemotactic factor. Accumulating evidence has demonstrated that various types of cells can produce a large amount of IL-8/CXCL8 in response to a wide variety of stimuli, including proinflammatory cytokines, microbes and their products, and environmental changes such as hypoxia, reperfusion, and hyperoxia. Numerous observations have established IL-8/CXCL8 as a key mediator in neutrophil-mediated acute inflammation due to its potent actions on neutrophils. However, several lines of evidence indicate that IL-8/CXCL8 has a wide range of actions on various types of cells, including lymphocytes, monocytes, endothelial cells, and fibroblasts, besides neutrophils. The discovery of these biological functions suggests that IL-8/CXCL8 has crucial roles in various pathological conditions such as chronic inflammation and cancer. Here, an overview of its protein structure, mechanisms of production, and receptor system will be discussed as well as the pathophysiological roles of IL-8/CXCL8 in various types of lung pathologies.

Từ khóa


Tài liệu tham khảo

10.1165/ajrcmb.22.1.3400

10.1089/10430340050015996

10.1034/j.1399-3003.2000.15e14.x

10.1074/jbc.271.34.20545

Aihara M, 1997, Infect Immun, 65, 3218, 10.1128/IAI.65.8.3218-3224.1997

10.1128/JVI.75.14.6450-6459.2001

10.1152/ajplung.2000.278.2.L253

10.1084/jem.182.1.155

10.1172/JCI118734

10.1038/385347a0

Bacon KB, 1994, Immunology, 82, 473

10.1146/annurev.immunol.15.1.675

10.1038/34193

10.1073/pnas.88.2.502

10.1002/jlb.66.1.144

10.1164/ajrccm.160.supplement_1.17

Bellocq A, 1998, Am J Pathol, 152, 83

Belperio JA, 2000, J Leukoc Biol, 68, 1

10.1164/ajrccm.149.3.7509706

10.1016/0006-291X(91)91418-C

10.1074/jbc.273.43.28040

10.1006/cyto.1999.0518

Broaddus VC, 1994, J Immunol, 152, 2960

10.1111/1523-1747.ep12462781

Burger M, 1999, J Immunol, 163, 2017

Burns AR, 1996, J Immunol, 156, 3389

10.1021/bi00209a002

Bussolino F, 1992, J Biol Chem, 267, 14598, 10.1016/S0021-9258(18)42083-2

10.1126/science.8036519

10.1164/ajrccm.149.3.8118632

10.1172/JCI115501

10.1016/0006-291X(89)92009-3

10.4049/jimmunol.164.11.5944

10.1074/jbc.271.6.2935

Chuntharapai A, 1994, J Immunol, 155, 2587

Chuntharapai A, 1994, J Immunol, 153, 5682

10.1006/mpat.1997.0169

10.1084/jem.170.5.1787

10.1080/019021499270187

10.1164/ajrccm.162.6.9911020

10.1164/ajrccm.165.2.2011151

10.1172/JCI4017

10.1084/jem.171.4.1155

10.1172/JCI118275

Djeu JY, 1990, J Immunol, 144, 2205

10.1016/0140-6736(93)90416-E

10.1038/379742a0

10.1097/00024382-200014030-00007

Dunlevy JR, 1995, J Cell Sci, 108, 311, 10.1242/jcs.108.1.311

10.1007/s100380050135

10.1152/ajpheart.1986.251.2.H314

10.1183/09031936.98.11020299

10.1172/JCI118009

10.1084/jem.192.6.881

Friedl HP, 1990, Am J Pathol, 136, 491

Friedland JS, 1992, Infect Immun, 60, 2402, 10.1128/IAI.60.6.2402-2408.1992

10.1034/j.1398-9995.1999.00891.x

Geiser T, 1993, J Biol Chem, 268, 15419, 10.1016/S0021-9258(18)82274-8

10.1084/jem.188.2.405

10.1172/JCI4461

10.1038/19546

10.1378/chest.119.5.1329

10.4049/jimmunol.165.9.5287

Hack CE, 1992, Infect Immun, 60, 2835, 10.1128/IAI.60.7.2835-2842.1992

Hebert CA, 1990, J Immunol, 145, 3033

10.1164/ajrccm.160.3.9901091

10.1126/science.287.5455.1049

10.1126/science.1840701

10.1152/ajplung.1990.259.4.L315

10.1126/science.1718038

10.1006/bbrc.2000.3925

Ikeda N, 1995, Infect Immun, 63, 4812, 10.1128/IAI.63.12.4812-4817.1995

10.1016/S0891-5849(00)00218-5

Jinquan T, 1997, J Immunol, 158, 475

10.1093/infdis/175.2.323

10.1073/pnas.93.13.6682

Keane MP, 1997, J Immunol, 159, 1437

Keane MP, 1999, J Immunol, 163, 5686

Keane MP, 1999, J Immunol, 162, 5511

10.1084/jem.186.7.1077

Kimata H, 1995, Blood, 85, 3191, 10.1182/blood.V85.11.3191.bloodjournal85113191

10.1084/jem.176.4.1227

Kitadai Y, 2000, Clin Cancer Res, 6, 2735

Kitadai Y, 1998, Am J Pathol, 152, 93

10.1074/jbc.271.5.2832

Ko YC, 1993, Infect Immun, 61, 1307, 10.1128/IAI.61.4.1307-1314.1993

10.1126/science.1281554

10.2739/kurumemedj.40.139

10.1152/ajpheart.1988.254.5.H823

Kudo C, 1991, J Immunol, 147, 2196

10.1172/JCI117680

Kuna P, 1991, J Immunol, 147, 1920

10.1016/S0002-9440(10)65174-7

10.1002/jlb.59.3.313

10.1164/ajrccm.163.2.2005109

10.1164/ajrccm.160.5.9901097

10.1164/ajrccm.157.2.97-02099

10.1126/science.2648569

10.4049/jimmunol.164.5.2769

10.1126/science.287.5455.1046

10.1016/S0076-6879(97)87022-X

10.1038/sj.onc.1203687

10.1056/NEJM199802123380706

10.1084/jem.182.1.219

Mahe Y, 1991, J Biol Chem, 266, 13759, 10.1016/S0021-9258(18)92765-1

10.1084/jem.173.4.1021

10.1086/515279

Matsumoto T, 1997, Lab Invest, 77, 119

10.1084/jem.169.4.1485

McCord JM., 1987, Fed Proc, 46, 2402

10.1016/S0092-8674(00)80422-5

10.1164/ajrccm.160.5.9901096

Mori N, 1998, Cancer Res, 58, 3993

10.1002/jlb.57.1.180

Mukaida N., 2000, Int J Hematol, 72, 391

10.1111/j.1348-0421.1992.tb02080.x

Mul FP, 2000, J Leukoc Biol, 68, 529

Murayama T, 1994, J Virol, 68, 7582, 10.1128/JVI.68.11.7582-7585.1994

Murayama T, 1997, J Virol, 71, 5692, 10.1128/JVI.71.7.5692-5695.1997

10.1034/j.1600-065X.2000.17715.x

10.1146/annurev.iy.12.040194.003113

Murphy PM, 2000, Pharmacol Rev, 52, 145

10.1126/science.1891716

10.1016/0014-5793(91)80526-9

10.1164/ajrccm.161.3.9906039

Nibbering PH, 1993, Infect Immun, 61, 3111, 10.1128/IAI.61.8.3111-3116.1993

10.1016/S0022-3476(98)70392-0

10.1146/annurev.iy.09.040191.003153

10.1016/0014-5793(94)00952-X

Paolini JF, 1994, J Immunol, 153, 2704

10.1073/pnas.96.17.9839

10.1128/JVI.75.13.6095-6106.2001

10.1128/JVI.75.13.6209-6211.2001

10.1126/science.8140420

10.1093/infdis/164.2.383

10.1074/jbc.270.46.27829

10.1074/jbc.273.37.23830

10.1016/0891-5849(96)00032-9

10.1159/000196514

Samanta AK, 1990, J Biol Chem, 265, 183, 10.1016/S0021-9258(19)40213-5

10.1084/jem.170.3.847

Schroder JM, 1987, J Immunol, 139, 3473

10.1038/365654a0

10.1126/science.287.5455.1037

10.1084/jem.179.5.1409

10.1152/jappl.1993.74.4.1994

10.1002/jlb.57.5.752

10.1074/jbc.270.45.27348

10.1165/ajrcmb.19.4.3165

10.1097/00006676-200007000-00051

Takizawa H, 1999, J Immunol, 162, 4705

Tsai WC, 1998, J Immunol, 161, 2435

10.1002/eji.1830190706

10.1002/eji.1830200933

10.1111/j.1432-1033.1989.tb14729.x

Van Zee KJ, 1991, J Immunol, 146, 3478

10.1002/ijc.2910490321

Warringa RA, 1991, Blood, 77, 2694, 10.1182/blood.V77.12.2694.2694

10.1016/0091-6749(93)90323-8

10.1172/JCI117316

10.1002/bjs.1800780607

Xu L, 1999, Cancer Res, 59, 5822

10.1378/chest.112.2.505

10.1084/jem.191.3.445

Yokoi K, 1997, Lab Invest, 76, 375

10.1073/pnas.84.24.9233

10.1016/0161-5890(89)90024-2

10.1164/ajrccm.157.3.9705014

10.1016/S1074-7613(00)80165-X